141 – Survival Analysis of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients in the Randomized Forte Trial Abstract Presentation Abstract View author list and disclosures Author(s): Francesca Gay, MD, Pellegrino Musto, Delia Rota Scalabrini*, Monica Galli*, Angelo Belotti, MD*, Elena Zamagni, MD*, Luca Bertamini, MD*, Renato Zambello*, Micol Quaresima*, Giovanni De Sabbata*, Giuseppe Pietrantuono*, Mattia D’Agostino,…
1187 – Long-Term Survival and Gradual Recovery of B Cells in Patients with Refractory Large B Cell Lymphoma Treated with Axicabtagene Ciloleucel (Axi-Cel) Abstract Presentation Slides Abstract View author list and disclosures Author(s): Caron Jacobson, MD, MMSc1, Frederick L. Locke, MD2, Armin Ghobadi, MD3, David B. Miklos, MD, PhD4, Lazaros J. Lekakis, MD5*, Olalekan O.…
2375 – Analysis of Risk Factors for Hepatic Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients Abstract Presentation Abstract View author list and disclosures Author(s): Bernd Gruhn*, Grit Brodt, MD*, Jana Ernst, MD* and Jaspar Kloehn* Department of Pediatrics, Jena University Hospital, Jena, Germany*signifies non-member of ASH Disclosures: No relevant conflicts…
143 – Early Versus Late Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma: Long-Term Follow-up Analysis of the IFM 2009 Trial Abstract Presentation Abstract View author list and disclosures Author(s): Aurore Perrot, MD, PhD, Valerie Lauwers-Cances, Titouan Cazaubiel, Thierry Facon, MD, Denis Caillot, Lauriane Clement-Filliatre, Margaret Macro, Olivier Decaux, Karim Belhadj, MD, Mohamad Mohty,…
2375 – Analysis of Risk Factors for Hepatic Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients Abstract Presentation Abstract View author list and disclosures Author(s): Bernd Gruhn*, Grit Brodt, MD*, Jana Ernst, MD* and Jaspar Kloehn* Department of Pediatrics, Jena University Hospital, Jena, Germany*signifies non-member of ASH Disclosures: No relevant conflicts…
1369 – Long-Term Sustained Minimal Residual Disease (MRD) Negativity in Patients with Multiple Myeloma Treated with Continuous Lenalidomide Maintenance Therapy: A Clinical and Correlative Phase 2 Study Abstract Presentation Abstract View author list and disclosures Author(s): Benjamin Diamond, MD, Neha Korde, MD, Alexander M. Lesokhin, MD, Eric L Smith, MD, PhD, Urvi A Shah, MD,…
984 – Ponatinib and Chemotherapy in Young Adults with De Novo Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia. Results of Ponalfil Clinical Trial after Completion of Recruitment Abstract Presentation Slides Abstract View author list and disclosures Author(s): Josep-Maria Ribera, Olga García, Pau Montesinos, MD, PhD, Pilar Martinez, MD, Jordi Esteve, MD, PhD, Daniel Esteban, María José Moreno,…
398 – Prognostic Significance of Genetic Alterations in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated with Hyper-CVAD Plus Dasatinib or Hyper-CVAD Plus Ponatinib Abstract Presentation Slides Abstract View author list and disclosures Author(s): Yuya Sasaki, MD, PhD, Hagop M. Kantarjian, MD, Nicholas J. Short, MD, Nitin Jain, MD, Koji Sasaki, MD, Farhad Ravandi, MBBS,…
1026 – Ponatinib Versus Imatinib with Reduced-Intensity Chemotherapy in Patients with Newly Diagnosed Philadelphia Chromosome–Positive (Ph+) Acute Lymphoblastic Leukemia (ALL): Phallcon Study Abstract Presentation Slides Abstract View author list and disclosures Author(s): Elias Jabbour, MD, Giovanni Martinelli, MD, Marco Vignetti, MD, Hagop M. Kantarjian, MD, David Gomez-Almaguer, MD, Yosuke Minami, MD, PhD, Hervé Dombret, MD,…
2842 – A Phase 1/2 Study to Evaluate the Safety and Efficacy of Ponatinib with Chemotherapy in Pediatric Patients with Philadelphia Chromosome–Positive (Ph+) Acute Lymphoblastic Leukemia (ALL) Abstract Presentation Abstract View author list and disclosures Author(s): Yousif Matloub, MD, Lia Gore, MD, Mignon L. Loh, MD, Chin-Hon Pui, MD, Michael J. Hanley, PharmD, PhD, Vickie…